Original Text: |
    Patients with a known germline or somatic BRCA pathogenic mutation should have a prior PARP inhibitor and subsequent progression, unless they have a documented history of intolerance or inability to swallow oral medications
Disease/Condition: BRCA1/2 mutation
Procedure: none
Drug: none
Biomarker: BRCA1/2 mutation
Computable Rule: |
    Disease is "BRCA1/2 mutation" AND Prior PARP inhibitor is False OR Prior PARP inhibitor is True AND Subsequent progression is False
